Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

minichart.com.sg
minichart.com.sg > 09/09/2026 > g-iii-apparel-q2-net-sales-fall-9-6-to-554-1-million

G-III Apparel Q2 Net Sales Fall 9.6% to $554.1 Million

4+ day, 13+ hour ago   (118+ words) minichart.com.sg G-III Apparel Q2 Net Sales Fall 9.6% to $554.1 Million G-III Apparel reported second-quarter fiscal 2026 net sales of $554.1 million for the three months ended July 31, 2026, a 9.6% decline from $613.3 million in the same period last year. Net income for the quarter…...

Minichart
minichart.com.sg > 09/09/2026 > elite-express-stockholders-approve-2026-stock-incentive-plan

Elite Express Stockholders Approve 2026 Stock Incentive Plan

4+ day, 13+ hour ago   (92+ words) Minichart Elite Express Stockholders Approve 2026 Stock Incentive Plan and Re-Elect Board at Annual Meeting Elite Express Holding Inc. (NASDAQ: ETS) announced that stockholders approved the company’s new 2026 Stock Incentive Plan at its Annual Meeting held on September 2, 2026. The plan, previously…...

Minichart
minichart.com.sg > 09/05/2026 > paid-extends-embolx-forbearance-agreement-to-october-31

PAID Extends Embolx Forbearance Agreement to October 31

1+ week, 1+ day ago   (305+ words) Minichart PAID Extends Embolx Forbearance Agreement to October 31 PAID, Inc. has extended its forbearance agreement with Embolx, Inc. to October 31, 2026, continuing to defer collection on a secured note with a Default Balance of $6,956,168. The extension was formalized through a letter…...

Minichart
minichart.com.sg > 08/25/2026 > ensysce-faces-nasdaq-delisting-risk-after-cy-biopharma-deal-triggers-change-of-control

Ensysce Faces Nasdaq Delisting Risk After Cy Biopharma Deal Triggers Change of Control

2+ week, 4+ day ago   (347+ words) Minichart Ensysce Faces Nasdaq Delisting Risk After Cy Biopharma Deal Triggers Change of Control Ensysce Biosciences Secures Nasdaq Extensions on Bid Price and Equity Compliance, Faces New Hurdle After Cy Biopharma Acquisition Ensysce Biosciences (Nasdaq: ENSC) announced on August 25, 2026, that…...

Minichart
minichart.com.sg > 08/24/2026 > volitionrx-issues-773361-shares-to-satisfy-400000-convertible-note-obligations

VolitionRx Issues 773,361 Shares to Satisfy $400,000 Convertible Note Obligations

2+ week, 5+ day ago   (241+ words) Minichart VolitionRx Issues 773,361 Shares to Satisfy $400,000 Convertible Note Obligations VolitionRx Issues 773,361 Shares to Satisfy $400,000 in Convertible Note Obligations VolitionRx Limited (NYSE American: VNRX) disclosed in an SEC Form 8-K filed August 24, 2026, that it issued an aggregate of 773,361 shares of common…...

Minichart
minichart.com.sg > 08/20/2026 > fs-kkr-capital-shareholders-approve-below-nav-share-sales

FS KKR Capital shareholders approve below-NAV share sales

3+ week, 2+ day ago   (295+ words) Minichart We value your privacy No cookies to display. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Advertisement cookies are used to provide visitors with…...

Minichart
minichart.com.sg > 08/18/2026 > vireo-growth-announces-buyback-of-up-to-2-4-million-shares

Vireo Growth Announces Buyback of Up to 2.4 Million Shares

3+ week, 4+ day ago   (235+ words) Minichart Vireo Growth Announces Buyback of Up to 2.4 Million Shares Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) announced a new share buyback program, authorizing the repurchase of up to 2,426,872 subordinate voting shares in the open market. The repurchases will be…...

Minichart
minichart.com.sg > 08/15/2026 > keycorp-redeems-all-525m-series-d-preferred-stock

KeyCorp Redeems All $525M Series D Preferred Stock

4+ week, 1+ day ago   (163+ words) KeyCorp to Redeem All $525 Million of Series D Preferred Stock KeyCorp (NYSE: KEY) announced it will redeem all 525,000 outstanding depositary shares of its Series D Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock on September 15, 2026. The redemption price is $1,012.50 per depositary share…...